No drug ads or Pharma sponsors dot the website of the Child & Adolescent Bipolar Foundation which has renamed itself the Zen-like “Balanced Mind Foundation.” (Meditation/medication–same idea, right?) Instead, visitors to the site will find slick slide shows, tales of children saved by bipolar drugs and a list of donor families. But according to the Journal of the American Academy of Child and Adolescent Psychiatry the actual guidelines the Balanced Mind Foundation uses to discern bipolar disorder in children and adolescents were funded by Abbott, AstraZeneca, Eli Lilly, Forest, Janssen, Novartis and Pfizer. Oops.
The most glaring omission in this study is whether the children who were having sleep problems, and who were all under psychiatric “care”, were being prescribed psychostimulants (Ritalin, Adderall, Concerta) in the first place. These drugs are in the same category of highly addictive substances as cocaine according to the U.S. Drug Enforcement Administration. That would account for the children’s inability to sleep. And instead of referring to this condition as “sleep disorder” a term which enables psychiatrists to prescribe even more drugs, we should demand to know what drugs psychiatrists had prescribed these children that stripped them of one of the most vital natural functions every child needs—sleep.
As a main component of the Psychopharmaceutical Industrial Complex, the so-called “patient advocacy” organizations have become the leading force behind the American epidemic of mental illness over the past two decades. Drug makers, and their foundations, funnel millions of dollars to these non-profits every year. In return, the leaders recruit their members as foot soldiers to carry out the latest marketing campaigns and to provide a fire-wall so that no money trail can be tracked back to the drug companies.